Rashad W Lilly, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1503 Emerald Lake Cir Apt 103, Elizabeth City, NC 27909 Phone: 757-706-1208 |
News Archive
Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.
The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.
Parkinson's disease (PD) is a progressive neurological condition. At present, it is usually diagnosed only when motor features are present. Hence, there is a need to develop objective and measurable biomarkers to improve PD diagnostics during its earlier stage, prior to its motor onset. In this pilot study, researchers identified and tested the first blood-based circulating microRNA (miRNA) biomarkers for PD.
In homes across the country, there are dangerous products hidden in plain sight on bathroom counters and bedroom dressers.
While exposure to high concentrations of the element in drinking water and in the workplace has been shown to be associated with diabetes, little is known about the effect of lower levels on diabetes risk.
› Verified 3 days ago